Literature DB >> 11929794

Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Charles H Pegelow1, Eric A Macklin, Franklin G Moser, Winfred C Wang, Jacqueline A Bello, Scott T Miller, Elliott P Vichinsky, Michael R DeBaun, Ludovico Guarini, Robert A Zimmerman, Donald P Younkin, Dianne M Gallagher, Thomas R Kinney.   

Abstract

Children with sickle cell anemia (HbSS) are at high risk for neurologically overt cerebral infarcts associated with stroke and neurologically silent cerebral infarcts correlated with neuropsychometric deficit. We used complete magnetic resonance imaging (MRI) histories from 266 HbSS children, aged 6 through 19 years, who were enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD) to examine silent infarct prevalence, localization, recurrence, and progression. We report a baseline prevalence of 21.8%, marginally higher than previously reported due to improved imaging technologies. Although we observed no overall sex difference in prevalence, most lesions in girls occurred before age 6, whereas boys remained at risk until age 10. Silent infarcts were significantly smaller and less likely to be found in the frontal or parietal cortex than were infarcts associated with stroke. Children with silent infarct had an increased incidence of new stroke (1.03/100 patient-years) and new or more extensive silent infarct (7.06/100 patient-years) relative to stroke incidence among all children in our cohort (0.54/100 patient-years). Both events were substantially less frequent than the risk of stroke recurrence among children not provided chronic transfusion therapy. Although chronic transfusion is known to decrease occurrence of new silent infarcts and strokes in children with elevated cerebral arterial blood flow velocity, further study is required to determine its risk-benefit ratio in children with silent infarct and normal velocities. Until safe and effective preventive strategies against infarct recurrence are discovered, MRI studies are best reserved for children with neurologic symptoms, neuropsychometric deficits, or elevated cerebral artery velocities.

Entities:  

Mesh:

Year:  2002        PMID: 11929794     DOI: 10.1182/blood.v99.8.3014

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  84 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

Review 2.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

3.  Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.

Authors:  Nancy S Green; Monica Bhatia; Erica Y Griffith; Mahvish Qureshi; Courtney Briamonte; Mirko Savone; Stephen Sands; Margaret T Lee; Angela Lignelli; Adam M Brickman
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-09       Impact factor: 5.742

4.  Transcranial Doppler screening in sickle cell disease: The implications of using peak systolic criteria.

Authors:  Lena N Naffaa; Yasmeen K Tandon; Neville Irani
Journal:  World J Radiol       Date:  2015-02-28

5.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

6.  MRI/MRA evaluation of sickle cell disease of the brain.

Authors:  Robert A Zimmerman
Journal:  Pediatr Radiol       Date:  2005-02-10

7.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

8.  Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy.

Authors:  Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Yasheng Chen; Cihat Eldeniz; Monica L Hulbert; Michael M Binkley; James N Rhodes; Joshua S Shimony; Robert C McKinstry; Katie D Vo; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Pediatr Neurol       Date:  2016-12-07       Impact factor: 3.372

9.  Neuroimaging in patients with sickle cell anemia: capacity building in Africa.

Authors:  Mboka Jacob; Dawn E Saunders; Jamie M Kawadler; Balowa Mussa; Russell Murdoch; Winok Lapidaire; Furahini Tluway; Ramadhan R Kazema; Siana Nkya; Magda Ahmed; Edward Kija; Lulu Fundikira; Frank Kussaga; Angela Darekar; Hilda Tutuba; Karin Shmueli; Christopher A Clark; Julie Makani; Fenella J Kirkham
Journal:  Blood Adv       Date:  2018-11-30

10.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.